A study found that IL-6 is a good marker of peripancreatic necrosis (Karpavicius et al., 2016), and previously published results showed that IPN can aggravate prognosis (Kolber et al., 2018). The gene discussed is IL6; the disease is bile duct papillary neoplasm.